Researchers at Penn Medicine say the revolutionary cancer treatment CAR-T therapy may also help patients with kidney failure.

Strong initial responses in 4 of 6 patients after many standard drugs had failed ...

Leland Metheny, MD, is lead investigator for the Phase 1 BAFF CAR T clinical trial, which is evaluating the safety and effectiveness of a novel approach to chimeric antigen receptor (CAR) T-cell ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Regulatory trials of chimeric antigen receptor T-cell therapies for autoimmune diseases could be ...

Caribou Biosciences announces new clinical trials and leadership appointments, highlighting progress in CAR-T therapy for various cancers and lupus. Caribou Biosciences, Inc. announced the initiation ...

Colleen Mabasa reflected on the importance of self-advocacy, as well as seeking second opinions and ensuring patients understand all available options. Colleen Mabasa, a patient with multiple myeloma, ...

Targeting KMA seeks to spare normal immunoglobulin-producing plasma cells, differentiating from BCMA-directed CAR T approaches associated with broader plasma-cell depletion and infectious ...

In the clinical battle against leukemia, recent breakthroughs in chimeric antigen receptor T cells (CAR T) have given patients and doctors an unprecedented weapon. CAR T cell therapy has demonstrated ...

Leading rheumatologist-researchers have assembled a comprehensive guide for initiating and managing CAR T-cell trials for systemic lupus erythematosus (SLE). It appears in ACR Open Rheumatology.